IP Library Granted Patent US 12,239,333
Granted Patent B2
US 12,239,333 · App. 18/497,249 · Granted Mar 4, 2025

Single insertion delivery system for treating embolism and associated systems and methods

Inventors: Richard Quick (Mission Viejo, CA); Benjamin Edward Merritt (San Clemente, CA); John Coleman Thress (Capistrano Beach, CA); Paul Lubock (Monarch Beach, CA); Thomas M. Tu (Louisville, KY)
Assignee: Inari Medical, Inc.
A61B17/22031A61B17/22A61B17/221A61M25/0082A61M39/06A61B2017/00907A61B2017/22034A61B2017/22042A61B2017/22079A61B2017/22094A61B2217/005A61M2210/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,333
App. No.
18/497,249
Filed
Oct 30, 2023
Granted
Mar 4, 2025
Kind
B2
Art Unit
3771
USPC
606/200
Abstract

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, engaging an interventional device of a catheter system with clot material in a blood vessel and withdrawing the interventional device and the portion of the clot material through a guide catheter. In some embodiments, the catheter system can include an attachment/valve member coupled to a proximal portion of the guide catheter, and the method can include unsealing the attachment/valve member to facilitate withdrawing the interventional device through the attachment/valve member without significant retention of clot material within the attachment/valve member. The method can further include resealing and aspirating the guide catheter before advancing another interventional device to the clot material to again engage and remove clot material from the blood vessel.

Claims (102)

1. A clot collection reservoir, comprising:

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to an aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to an aspiration source, wherein the second port provides a second fluid path from the chamber; and

a filter removably positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port;

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port; and

wherein the housing is at least partially transparent to permit visualization of the clot material in the chamber outside the interior region.

2. The clot collection reservoir of claim 1 wherein the second port is positioned proximate to the second housing end portion.

3. The clot collection reservoir of claim 1 , further comprising a cap configured to be releasably coupled to the second housing end portion, wherein the cap is removable from the housing to provide access to the filter.

4. The clot collection reservoir of claim 1 wherein the first filter end portion is curved.

5. The clot collection reservoir of claim 1 wherein the source of aspiration is configured to generate the negative pressure in the chamber via the second port to draw the clot material against the first filter end portion.

6. The clot collection reservoir of claim 1 wherein the housing is entirely transparent, and wherein the first port is integrally formed with the housing.

7. The clot collection reservoir of claim 1 wherein the first filter end portion is positioned closer to the first housing end portion than the second filter end portion, and wherein the second filter end portion is positioned closer to the second housing end portion than the first filter end portion.

8. A clot collection reservoir, comprising:

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to an aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to an aspiration source, wherein the second port provides a second fluid path from the chamber;

a cap configured to be releasably coupled to the second housing end portion; and

a filter coupled to the cap and configured to be positioned when the chamber when the cap is releasably coupled to the second housing end portion, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port;

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port;

wherein the housing is at least partially transparent to permit visualization of the clot material in the chamber outside the interior region; and

wherein the cap is removable from the housing to provide access to the filter.

9. A clot collection reservoir, comprising:

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to an aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to an aspiration source, wherein the second port provides a second fluid path from the chamber;

a cap configured to be releasably coupled to the second housing end portion; and

a filter positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port;

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port;

wherein the housing is at least partially transparent to permit visualization of the clot material in the chamber outside the interior region; and

wherein the cap and the filter are removable from the housing to provide access to the clot material within the chamber.

10. A clot treatment system, comprising:

an aspiration catheter configured to be intravascularly positioned proximate to clot material within a blood vessel of a patient;

an aspiration source; and

a clot collection reservoir, comprising—

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to the aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to the aspiration source, wherein the second port provides a second fluid path to the chamber; and

a filter positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port;

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port; and

wherein the filter is removably positioned within the chamber to provide access to the clot material within the chamber.

11. The clot treatment system of claim 10 wherein the housing is at least partially transparent to permit visualization of the clot material in the chamber outside the interior region.

12. The clot treatment system of claim 10 wherein the second port is positioned proximate to the second housing end portion.

13. The clot treatment system of claim 10 wherein the clot collection reservoir is spaced apart from the aspiration source, and further comprising at least one tube fluidly coupling the second port to the aspiration source.

14. A clot treatment system, comprising:

an aspiration catheter configured to be intravascularly positioned proximate to clot material within a blood vessel of a patient;

an aspiration source; and

a clot collection reservoir, comprising—

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to the aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to the aspiration source, wherein the second port provides a second fluid path to the chamber;

a cap configured to be releasably coupled to the second housing end portion; and

a filter positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port;

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port; and

wherein the cap and the filter are removable from the housing to provide access to the clot material within the chamber.

15. A clot treatment system, comprising:

an aspiration catheter configured to be intravascularly positioned proximate to clot material within a blood vessel of a patient;

an aspiration source;

a clot collection reservoir, comprising—

a housing defining a sealed chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to the aspiration catheter, wherein the first port is positioned proximate to the first housing end portion and provides a first fluid path to the chamber;

a second port configured to be fluidly coupled to the aspiration source, wherein the second port provides a second fluid path to the chamber; and

a filter positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port; and

a valve positioned between the clot collection reservoir and the aspiration catheter, wherein the valve is user-actuatable to move between (a) an open position in which the first port is fluidly connected to the aspiration catheter and (b) a closed position in which the first port is fluidly disconnected from the aspiration catheter;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port; and

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port.

16. The clot treatment system of claim 15 wherein the aspiration source is configured to generate the negative pressure in the chamber with the valve in the closed position, and wherein the valve is configured to be moved to the open position to apply the negative pressure to the aspiration catheter.

17. A clot treatment system, comprising:

an aspiration catheter configured to be intravascularly positioned proximate to clot material within a blood vessel of a patient;

a hemostasis valve coupled to a proximal portion of the aspiration catheter;

at least one tube fluidly coupling the first port to a portion of the aspiration catheter distal of the hemostasis valve;

an aspiration source; and

a clot collection reservoir, comprising—

a housing defining a chamber and having a first housing end portion and a second housing end portion opposite the first housing end portion;

a first port configured to be fluidly coupled to the aspiration catheter, wherein the first port is positioned proximate to the first housing end portion;

a second port configured to be fluidly coupled to the aspiration source; and

a filter positioned within the chamber, wherein the filter has a substantially cylindrical shape extending from a first filter end portion to a second filter end portion, and wherein the filter extends continuously about the first filter end portion such that the filter encloses an interior region around the second port;

wherein the aspiration source is configured to generate negative pressure in the chamber via the second port to (a) draw blood and clot material from the aspiration catheter through the first port into the chamber and (b) draw blood through the filter into the interior region and through the second port; and

wherein the filter is configured to inhibit the clot material from passing through the filter into the interior region and through the second port.

18. The clot treatment system of claim 17 wherein the hemostasis valve comprises:

a tubular member;

a button; and

a filament coupled to the button and the tubular member, wherein the button is actuatable to loosen the filament to unseal the hemostasis valve.

19. The clot treatment system of claim 17 wherein the aspiration source is fluidly couplable to the at least one tube.

20. The clot treatment system of claim 17 wherein the hemostasis valve is configured to receive an instrument therethrough.

21. The clot treatment system of claim 17 wherein the hemostasis valve and the aspiration catheter are configured to receive and route an instrument therethrough.

22. The clot treatment system of claim 17 wherein the hemostasis valve comprises:

a tubular member defining a lumen;

a first filament extending in a first loop around the tubular member;

a second filament extending in a second loop around the tubular member; and

a pair of actuators biased to circumferentially constrict the first loop and the second loop to elastically deform the tubular member to a first position in which the lumen is constricted, wherein at least one the actuators is movable to decrease a level of tension in the first filament and a level of tension in the second filament to permit the tubular member to expand against the first loop and the second loop to a second position in which the lumen of the tubular member is at least partially open.

23. The clot treatment system of claim 22 wherein the actuators each comprise a button.

24. The clot treatment system of claim 22 wherein the first filament includes a first portion operably coupled to a first one of the actuators and a second portion operably coupled to a second one of the actuators, and wherein the second filament includes a first portion operably coupled to the first one of the actuators and a second portion operably coupled to the second one of the actuators.

25. The clot treatment system of claim 22 wherein the first filament is flexible, and wherein the second filament is flexible.

26. The clot treatment system of claim 17 wherein the aspiration catheter has a size of at least 16 French.

27. The clot treatment system of claim 17 wherein the aspiration catheter has a size of at least 20 French.

28. The clot treatment system of claim 17 wherein the aspiration catheter has a size of at least 22 French.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 29, 2026
From: INARI MEDICAL, INC.
To: STRYKER CORPORATION
Reel/Frame 075486/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2024
From: QUICK, RICHARD; MERRITT, BENJAMIN EDWARD; THRESS, JOHN COLEMAN; LUBOCK, PAUL; TU, THOMAS M.
To: INARI MEDICAL, INC.
Reel/Frame 066105/0181 →
Continuity (5)
Continuation 17865307 · Jul 14, 2022
Continuation 17498642 · Oct 11, 2021
Continuation 16258344 · Jan 25, 2019
Provisional Application 62622691 · Jan 26, 2018
Related Publication 20240074771A1 · Mar 7, 2024
References Cited (400)
US 1101890A · Tunstead · 1914 [cited by applicant]
US 2502639A · Blake · 1948 [cited by applicant]
US 2707954A · Kas, Sr. · 1955 [cited by applicant]
US 2784717A · Thompson · 1957 [cited by applicant]
US 2846179A · Monckton · 1958 [cited by applicant]
US 2955592A · Maclean · 1960 [cited by applicant]
US 3088363A · Sparks · 1963 [cited by applicant]
US 3197173A · Taubenheim · 1965 [cited by applicant]
US 3383131A · Rosfelder · 1968 [cited by applicant]
US 3416531A · Edwards · 1968 [cited by applicant]
US 3435826A · Fogarty · 1969 [cited by applicant]
US 3438607A · Williams et al. · 1969 [cited by applicant]
US 3515137A · Santomieri · 1970 [cited by applicant]
US 3661144A · Jensen · 1972 [cited by examiner]
US 3675657A · Gauthier · 1972 [cited by applicant]
US 3785380A · Brumfield · 1974 [cited by examiner]
US 3860006A · Patel · 1975 [cited by applicant]
US 3863624A · Gram · 1975 [cited by examiner]
US 3892161A · Sokol · 1975 [cited by applicant]
US 3923065A · Nozick et al. · 1975 [cited by applicant]
US 4030503A · Clark, III · 1977 [cited by applicant]
US 4034642A · Iannucci et al. · 1977 [cited by applicant]
US 4036232A · Genese · 1977 [cited by applicant]
US 4187849A · Stim · 1980 [cited by applicant]
US 4222380A · Terayama · 1980 [cited by applicant]
US 4243040A · Beecher · 1981 [cited by applicant]
US 4287808A · Leonard et al. · 1981 [cited by applicant]
US 4324262A · Hall · 1982 [cited by applicant]
US 4393872A · Reznik et al. · 1983 [cited by applicant]
US 4401107A · Harber et al. · 1983 [cited by applicant]
US 4469100A · Hardwick · 1984 [cited by applicant]
US 4523738A · Raftis et al. · 1985 [cited by applicant]
US 4551862A · Haber · 1985 [cited by applicant]
US 4604094A · Shook · 1986 [cited by applicant]
US 4611594A · Grayhack et al. · 1986 [cited by applicant]
US 4634421A · Hegemann · 1987 [cited by applicant]
US 4643184A · Mobin-Uddin · 1987 [cited by applicant]
US 4646736A · Auth et al. · 1987 [cited by applicant]
US 4650466A · Luther · 1987 [cited by applicant]
US 4693257A · Markham · 1987 [cited by applicant]
US 4705518A · Baker et al. · 1987 [cited by applicant]
US 4776337A · Palmaz · 1988 [cited by applicant]
US 4790812A · Hawkins, Jr. et al. · 1988 [cited by applicant]
US 4826483A · Molnar, IV · 1989 [cited by applicant]
US 4863440A · Chin et al. · 1989 [cited by applicant]
US 4870953A · DonMichael et al. · 1989 [cited by applicant]
US 4880408A · Cumes et al. · 1989 [cited by applicant]
US 4883458A · Shiber · 1989 [cited by applicant]
US 4886062A · Wiktor · 1989 [cited by applicant]
US 4890611A · Monfort et al. · 1990 [cited by applicant]
US 4898575A · Fischell et al. · 1990 [cited by applicant]
US 4946440A · Hall · 1990 [cited by applicant]
US 4960259A · Sunnanvader et al. · 1990 [cited by applicant]
US 4978341A · Niederhauser · 1990 [cited by applicant]
US 4981478A · Evard et al. · 1991 [cited by applicant]
US 5030201A · Palestrant · 1991 [cited by applicant]
US 5053008A · Bajaj · 1991 [cited by applicant]
US 5059178A · Ya · 1991 [cited by applicant]
US 5100423A · Fearnot · 1992 [cited by applicant]
US 5127626A · Hilal et al. · 1992 [cited by applicant]
US 5129910A · Phan et al. · 1992 [cited by applicant]
US 5135484A · Wright · 1992 [cited by applicant]
US 5154724A · Andrews · 1992 [cited by applicant]
US 5158533A · Strauss et al. · 1992 [cited by applicant]
US 5158564A · Schnepp-Pesch et al. · 1992 [cited by applicant]
US 5192274A · Bierman · 1993 [cited by applicant]
US 5192286A · Phan et al. · 1993 [cited by applicant]
US 5192290A · Hilal · 1993 [cited by applicant]
US 5197485A · Grooters · 1993 [cited by applicant]
US 5234403A · Yoda et al. · 1993 [cited by applicant]
US 5242461A · Kortenbach et al. · 1993 [cited by applicant]
US 5244619A · Burnham · 1993 [cited by applicant]
US 5246011A · Caillouette · 1993 [cited by applicant]
US 5323514A · Masuda et al. · 1994 [cited by applicant]
US 5329923A · Lundquist · 1994 [cited by applicant]
US 5360417A · Gravener et al. · 1994 [cited by applicant]
US 5364345A · Lowery et al. · 1994 [cited by applicant]
US 5376071A · Henderson · 1994 [cited by applicant]
US 5376101A · Green et al. · 1994 [cited by applicant]
US 5383887A · Nadal · 1995 [cited by applicant]
US 5389100A · Bacich et al. · 1995 [cited by applicant]
US 5391152A · Patterson et al. · 1995 [cited by applicant]
US 5419774A · Willard et al. · 1995 [cited by applicant]
US 5421824A · Clement et al. · 1995 [cited by applicant]
US 5429610A · Vaillancourt · 1995 [cited by applicant]
US 5429616A · Schaffer · 1995 [cited by applicant]
US 5443443A · Shiber · 1995 [cited by applicant]
US 5456667A · Ham et al. · 1995 [cited by applicant]
US 5476450A · Ruggio · 1995 [cited by applicant]
US 5484418A · Quiachon et al. · 1996 [cited by applicant]
US 5490859A · Mische et al. · 1996 [cited by applicant]
US 5496365A · Sgro · 1996 [cited by applicant]
US 5527326A · Hermann et al. · 1996 [cited by applicant]
US 5549626A · Miller et al. · 1996 [cited by applicant]
US 5591137A · Stevens · 1997 [cited by applicant]
US 5639276A · Weinstock et al. · 1997 [cited by applicant]
US 5653684A · Laptewicz et al. · 1997 [cited by applicant]
US 5662703A · Yurek et al. · 1997 [cited by applicant]
US 5746758A · Nordgren et al. · 1998 [cited by applicant]
US 5749858A · Cramer · 1998 [cited by applicant]
US 5769816A · Barbut et al. · 1998 [cited by applicant]
US 5782817A · Franzel et al. · 1998 [cited by applicant]
US 5800457A · Gelbfish · 1998 [cited by applicant]
US 5827229A · Auth et al. · 1998 [cited by applicant]
US 5846251A · Hart · 1998 [cited by applicant]
US 5860938A · Lafontaine et al. · 1999 [cited by applicant]
US 5873866A · Kondo et al. · 1999 [cited by applicant]
US 5873882A · Straub et al. · 1999 [cited by applicant]
US 5867385A · Ikari et al. · 1999 [cited by applicant]
US 5876414A · Straub · 1999 [cited by applicant]
US 5895406A · Gray et al. · 1999 [cited by applicant]
US 5908435A · Samuels · 1999 [cited by applicant]
US 5911710A · Barry et al. · 1999 [cited by applicant]
US 5911728A · Sepetka et al. · 1999 [cited by applicant]
US 5911733A · Parodi · 1999 [cited by applicant]
US 5911754A · Kanesaka et al. · 1999 [cited by applicant]
US 5938645A · Gordon · 1999 [cited by applicant]
US 5941869A · Patterson et al. · 1999 [cited by applicant]
US 5947985A · Imram · 1999 [cited by applicant]
US 5951539A · Nita et al. · 1999 [cited by applicant]
US 5954737A · Lee · 1999 [cited by applicant]
US 5971938A · Hart et al. · 1999 [cited by applicant]
US 5971958A · Zhang · 1999 [cited by applicant]
US 5972019A · Engelson et al. · 1999 [cited by applicant]
US 5974938A · Lloyd · 1999 [cited by applicant]
US 5989233A · Yoon · 1999 [cited by applicant]
US 5993483A · Gianotti · 1999 [cited by applicant]
US 6017335A · Burnham · 2000 [cited by applicant]
US 6030397A · Moneti et al. · 2000 [cited by applicant]
US 6059745A · Gelbfish · 2000 [cited by applicant]
US 6059814A · Ladd · 2000 [cited by applicant]
US 6066158A · Engelson et al. · 2000 [cited by applicant]
US 6068645A · Tu · 2000 [cited by applicant]
US 6126635A · Simpson et al. · 2000 [cited by applicant]
US 6142987A · Tsugita · 2000 [cited by applicant]
US 6146396A · Konya et al. · 2000 [cited by applicant]
US 6146403A · St. Germain · 2000 [cited by applicant]
US 6152144A · Lesh et al. · 2000 [cited by applicant]
US 6152909A · Bagaoisan et al. · 2000 [cited by applicant]
US 6152946A · Broome et al. · 2000 [cited by applicant]
US 6156055A · Ravenscroft · 2000 [cited by applicant]
US 6159230A · Samuels · 2000 [cited by applicant]
US 6165196A · Stack et al. · 2000 [cited by applicant]
US 6168579B1 · Tsugita · 2001 [cited by applicant]
US 6179859B1 · Bates et al. · 2001 [cited by applicant]
US 6221006B1 · Dubrul et al. · 2001 [cited by applicant]
US 6228060B1 · Howell · 2001 [cited by applicant]
US 6238412B1 · Dubrul et al. · 2001 [cited by applicant]
US 6245078B1 · Ouchi · 2001 [cited by applicant]
US 6245089B1 · Daniel et al. · 2001 [cited by applicant]
US 6254571B1 · Hart · 2001 [cited by applicant]
US 6258115B1 · Dubrul · 2001 [cited by applicant]
US 6264663B1 · Cano · 2001 [cited by applicant]
US 6306163B1 · Fitz · 2001 [cited by applicant]
US 6322572B1 · Lee · 2001 [cited by applicant]
US 6350271B1 · Kurz et al. · 2002 [cited by applicant]
US 6361545B1 · Macoviak et al. · 2002 [cited by applicant]
US 6364895B1 · Greenhalgh · 2002 [cited by applicant]
US 6368339B1 · Amplatz · 2002 [cited by applicant]
US 6383205B1 · Samson et al. · 2002 [cited by applicant]
US 6402771B1 · Palmer et al. · 2002 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6432122B1 · Gilson et al. · 2002 [cited by applicant]
US 6436085B1 · Lauer · 2002 [cited by applicant]
US 6451036B1 · Heitzmann et al. · 2002 [cited by applicant]
US 6458103B1 · Albert et al. · 2002 [cited by applicant]
US 6475236B1 · Roubin et al. · 2002 [cited by applicant]
US 6481439B1 · Lewis et al. · 2002 [cited by applicant]
US 6485502B2 · Don Michael · 2002 [cited by applicant]
US 6508782B1 · Evans et al. · 2003 [cited by applicant]
US 6511492B1 · Rosenbluth et al. · 2003 [cited by applicant]
US 6514273B1 · Voss et al. · 2003 [cited by applicant]
US 6530923B1 · Dubrul et al. · 2003 [cited by applicant]
US 6530935B2 · Wensel et al. · 2003 [cited by applicant]
US 6540722B1 · Boyle et al. · 2003 [cited by applicant]
US 6544276B1 · Azizi · 2003 [cited by applicant]
US 6544278B1 · Vrba et al. · 2003 [cited by applicant]
US 6544279B1 · Hopkins et al. · 2003 [cited by applicant]
US 6551342B1 · Shen et al. · 2003 [cited by applicant]
US 6564828B1 · Ishida · 2003 [cited by applicant]
US 6569181B1 · Burns · 2003 [cited by applicant]
US 6575995B1 · Huter et al. · 2003 [cited by applicant]
US 6589263B1 · Hopkins et al. · 2003 [cited by applicant]
US 6589264B1 · Barbut et al. · 2003 [cited by applicant]
US 6596011B2 · Johnson et al. · 2003 [cited by applicant]
US 6602271B2 · Adams et al. · 2003 [cited by applicant]
US 6605074B2 · Zadno-azizi et al. · 2003 [cited by applicant]
US 6605102B1 · Mazzocchi et al. · 2003 [cited by applicant]
US 6610077B1 · Hancock et al. · 2003 [cited by applicant]
US 6620148B1 · Tsugita · 2003 [cited by applicant]
US 6620179B2 · Brook et al. · 2003 [cited by applicant]
US 6620182B1 · Khosravi et al. · 2003 [cited by applicant]
US 6623460B1 · Heck · 2003 [cited by applicant]
US 6635068B1 · Dubrul et al. · 2003 [cited by applicant]
US 6645222B1 · Parodi et al. · 2003 [cited by applicant]
US 6660013B2 · Rabiner et al. · 2003 [cited by applicant]
US 6660014B2 · Demarais et al. · 2003 [cited by applicant]
US 6663650B2 · Sepetka et al. · 2003 [cited by applicant]
US 6692504B2 · Kurz et al. · 2004 [cited by applicant]
US 6699260B2 · Dubrul et al. · 2004 [cited by applicant]
US 6702830B1 · Demarais et al. · 2004 [cited by applicant]
US 6719717B1 · Johnson et al. · 2004 [cited by applicant]
US 6755847B2 · Eskuri · 2004 [cited by applicant]
US 6767353B1 · Shiber · 2004 [cited by applicant]
US 6776770B1 · Trerotola · 2004 [cited by applicant]
US 6790204B2 · Zadno-azizi et al. · 2004 [cited by applicant]
US 6800080B1 · Bates · 2004 [cited by applicant]
US 6818006B2 · Douk et al. · 2004 [cited by applicant]
US 6824545B2 · Sepetka et al. · 2004 [cited by applicant]
US 6824550B1 · Noriega et al. · 2004 [cited by applicant]
US 6824553B1 · Gene et al. · 2004 [cited by applicant]
US 6830561B2 · Jansen et al. · 2004 [cited by applicant]
US 6846029B1 · Ragner et al. · 2005 [cited by applicant]
US 6902540B2 · Dorros et al. · 2005 [cited by applicant]
US 6908455B2 · Hajianpour · 2005 [cited by examiner]
US 6939361B1 · Kleshinski · 2005 [cited by applicant]
US 6942682B2 · Vrba et al. · 2005 [cited by applicant]
US 6945977B2 · Demarais et al. · 2005 [cited by applicant]
US 6960189B2 · Bates et al. · 2005 [cited by applicant]
US 6960222B2 · Vo et al. · 2005 [cited by applicant]
US 7004931B2 · Hogendijk · 2006 [cited by applicant]
US 7004954B1 · Voss et al. · 2006 [cited by applicant]
US 7036707B2 · Aota et al. · 2006 [cited by applicant]
US 7041084B2 · Fotjik · 2006 [cited by applicant]
US 7052500B2 · Bashiri et al. · 2006 [cited by applicant]
US 7056328B2 · Arnott · 2006 [cited by applicant]
US 7063707B2 · Bose et al. · 2006 [cited by applicant]
US 7069835B2 · Nishri et al. · 2006 [cited by applicant]
US 7094249B1 · Thomas et al. · 2006 [cited by applicant]
US 7122034B2 · Belhe et al. · 2006 [cited by applicant]
US 7128073B1 · van der Burg et al. · 2006 [cited by applicant]
US 7152605B2 · Khairkhahan et al. · 2006 [cited by applicant]
US 7179273B1 · Palmer et al. · 2007 [cited by applicant]
US 7223253B2 · Hogendijk · 2007 [cited by applicant]
US 7232432B2 · Fulton, III et al. · 2007 [cited by applicant]
US 7244243B2 · Lary · 2007 [cited by applicant]
US 7285126B2 · Sepetka et al. · 2007 [cited by applicant]
US 7300458B2 · Henkes et al. · 2007 [cited by applicant]
US 7306618B2 · Demond et al. · 2007 [cited by applicant]
US 7320698B2 · Eskuri · 2008 [cited by applicant]
US 7323002B2 · Johnson et al. · 2008 [cited by applicant]
US 7331980B2 · Dubrul et al. · 2008 [cited by applicant]
US 7481805B2 · Magnusson · 2009 [cited by applicant]
US 7534234B2 · Fotjik · 2009 [cited by applicant]
US 7578830B2 · Kusleika et al. · 2009 [cited by applicant]
US 7621870B2 · Berrada et al. · 2009 [cited by applicant]
US 7674247B2 · Fotjik · 2010 [cited by applicant]
US 7678131B2 · Muller · 2010 [cited by applicant]
US 7691121B2 · Rosenbluth et al. · 2010 [cited by applicant]
US 7695458B2 · Belley et al. · 2010 [cited by applicant]
US 7713282B2 · Frazier et al. · 2010 [cited by applicant]
US 7722641B2 · van der Burg et al. · 2010 [cited by applicant]
US 7763010B2 · Evans et al. · 2010 [cited by applicant]
US 7766934B2 · Pal et al. · 2010 [cited by applicant]
US 7775501B2 · Kees · 2010 [cited by applicant]
US 7780696B2 · Daniel et al. · 2010 [cited by applicant]
US 7815608B2 · Schafersman et al. · 2010 [cited by applicant]
US 7837630B2 · Nicoson · 2010 [cited by examiner]
US 7905877B1 · Jilnenez et al. · 2011 [cited by applicant]
US 7905896B2 · Straub · 2011 [cited by applicant]
US 7938809B2 · Lampropoulos et al. · 2011 [cited by applicant]
US 7938820B2 · Webster et al. · 2011 [cited by applicant]
US 7967790B2 · Whiting et al. · 2011 [cited by applicant]
US 7976511B2 · Fotjik · 2011 [cited by applicant]
US 7993302B2 · Hebert et al. · 2011 [cited by applicant]
US 7993363B2 · Demond et al. · 2011 [cited by applicant]
US 7998104B2 · Chang · 2011 [cited by applicant]
US 8021351B2 · Boldenow et al. · 2011 [cited by applicant]
US 8043313B2 · Krolik et al. · 2011 [cited by applicant]
US 8052640B2 · Fiorella et al. · 2011 [cited by applicant]
US 8057496B2 · Fischer, Jr. · 2011 [cited by applicant]
US 8057497B1 · Raju et al. · 2011 [cited by applicant]
US 8066757B2 · Ferrera et al. · 2011 [cited by applicant]
US 8070694B2 · Galdonik et al. · 2011 [cited by applicant]
US 8070769B2 · Broome · 2011 [cited by applicant]
US 8070791B2 · Ferrera et al. · 2011 [cited by applicant]
US 8075510B2 · Aklog et al. · 2011 [cited by applicant]
US 8080032B2 · van Der Burg et al. · 2011 [cited by applicant]
US 8088140B2 · Ferrera et al. · 2012 [cited by applicant]
US 8092486B2 · Berrada et al. · 2012 [cited by applicant]
US 8100935B2 · Rosenbluth et al. · 2012 [cited by applicant]
US 8109962B2 · Pal · 2012 [cited by applicant]
US 8118275B2 · Mialhe · 2012 [cited by applicant]
US 8118829B2 · Carrison et al. · 2012 [cited by applicant]
US 8157760B2 · Criado et al. · 2012 [cited by applicant]
US 8187465B2 · Nierich · 2012 [cited by applicant]
US 8197493B2 · Ferrera et al. · 2012 [cited by applicant]
US 8246641B2 · Osborne et al. · 2012 [cited by applicant]
US 8261648B1 · Marchand et al. · 2012 [cited by applicant]
US 8267897B2 · Wells · 2012 [cited by applicant]
US 8298257B2 · Sepetka et al. · 2012 [cited by applicant]
US 8317748B2 · Fiorella et al. · 2012 [cited by applicant]
US 8337450B2 · Fotjik · 2012 [cited by applicant]
US RE43902E · Hopkins et al. · 2013 [cited by applicant]
US 8343167B2 · Henson · 2013 [cited by applicant]
US 8357178B2 · Grandfield et al. · 2013 [cited by applicant]
US 8361104B2 · Jones et al. · 2013 [cited by applicant]
US 8409215B2 · Sepetka et al. · 2013 [cited by applicant]
US 8439858B2 · Huang et al. · 2013 [cited by applicant]
US 8480708B2 · Kassab et al. · 2013 [cited by applicant]
US 8486105B2 · Demond et al. · 2013 [cited by applicant]
US 8491539B2 · Fotjik · 2013 [cited by applicant]
US 8512352B2 · Martin · 2013 [cited by applicant]
US 8523897B2 · van Der Burg et al. · 2013 [cited by applicant]
US 8529596B2 · Grandfield et al. · 2013 [cited by applicant]
US 8535283B2 · Heaton et al. · 2013 [cited by applicant]
US 8535334B2 · Martin · 2013 [cited by applicant]
US 8535343B2 · van Der Burg et al. · 2013 [cited by applicant]
US 8545526B2 · Martin et al. · 2013 [cited by applicant]
US 8568432B2 · Straub · 2013 [cited by applicant]
US 8568465B2 · Freudenthal et al. · 2013 [cited by applicant]
US 8574262B2 · Ferrera et al. · 2013 [cited by applicant]
US 8579915B2 · French et al. · 2013 [cited by applicant]
US 8585713B2 · Ferrera et al. · 2013 [cited by applicant]
US 8608754B2 · Wensel et al. · 2013 [cited by applicant]
US 8613717B2 · Aklog et al. · 2013 [cited by applicant]
US 8632584B2 · Henkes et al. · 2014 [cited by applicant]
US 8647367B2 · Kassab et al. · 2014 [cited by applicant]
US 8657867B2 · Dorn et al. · 2014 [cited by applicant]
US 8696622B2 · Fiorella et al. · 2014 [cited by applicant]
US 8715314B1 · Janardhan et al. · 2014 [cited by applicant]
US 8721714B2 · Kelley · 2014 [cited by applicant]
US 8734374B2 · Aklog et al. · 2014 [cited by applicant]
US 8753322B2 · Hu et al. · 2014 [cited by applicant]
US 8764730B2 · Taber · 2014 [cited by applicant]
US 8771289B2 · Mohiuddin et al. · 2014 [cited by applicant]
US 8777893B2 · Malewicz · 2014 [cited by applicant]
US 8784441B2 · Rosenbluth et al. · 2014 [cited by applicant]
US 8784442B2 · Jones et al. · 2014 [cited by applicant]
US 8784469B2 · Kassab · 2014 [cited by applicant]
US 8795305B2 · Martin et al. · 2014 [cited by applicant]
US 8795317B2 · Grandfield et al. · 2014 [cited by applicant]
US 8795345B2 · Grandfield et al. · 2014 [cited by applicant]
US 8801748B2 · Martin · 2014 [cited by applicant]
US 8808259B2 · Walton et al. · 2014 [cited by applicant]
US 8814927B2 · Shin et al. · 2014 [cited by applicant]
US 8820207B2 · Marchand et al. · 2014 [cited by applicant]
US 8826791B2 · Thompson et al. · 2014 [cited by applicant]
US 8828044B2 · Aggerholm et al. · 2014 [cited by applicant]
US 8833224B2 · Thompson et al. · 2014 [cited by applicant]
US 8834519B2 · van Der Burg et al. · 2014 [cited by applicant]
US 8845621B2 · Fotjik · 2014 [cited by applicant]
US 8852205B2 · Brady et al. · 2014 [cited by applicant]
US 8852226B2 · Gilson et al. · 2014 [cited by applicant]
US 8939991B2 · Krolik et al. · 2015 [cited by applicant]
US 8945143B2 · Ferrera et al. · 2015 [cited by applicant]
US 8945172B2 · Ferrera et al. · 2015 [cited by applicant]
US 8956384B2 · Berrada et al. · 2015 [cited by applicant]
US 8992504B2 · Castella et al. · 2015 [cited by applicant]
US 9005172B2 · Chung · 2015 [cited by applicant]
US 9011551B2 · Oral et al. · 2015 [cited by applicant]
US 9028401B1 · Bacich et al. · 2015 [cited by applicant]
US 9044575B2 · Beasley et al. · 2015 [cited by applicant]
US 9072537B2 · Grandfield et al. · 2015 [cited by applicant]
US 9078682B2 · Lenker et al. · 2015 [cited by applicant]
US 9101382B2 · Krolik et al. · 2015 [cited by applicant]
US 9125683B2 · Farhangnia et al. · 2015 [cited by applicant]
US 9126016B2 · Fulton · 2015 [cited by applicant]
US 9126020B2 · Farhangnia et al. · 2015 [cited by applicant]
US 9149609B2 · Ansel et al. · 2015 [cited by applicant]
US 9155552B2 · Ulm, III · 2015 [cited by applicant]
US 9161766B2 · Slee et al. · 2015 [cited by applicant]
US 9168043B2 · van Der Burg et al. · 2015 [cited by applicant]
US 9173668B2 · Ulm, III · 2015 [cited by applicant]
US 9186487B2 · Dubrul et al. · 2015 [cited by applicant]
US D744639S · Aklog et al. · 2015 [cited by applicant]
US 9204887B2 · Cully et al. · 2015 [cited by applicant]
US 9216277B2 · Myers · 2015 [cited by applicant]
US 9241669B2 · Pugh et al. · 2016 [cited by applicant]
US 9358037B2 · Farhangnia et al. · 2016 [cited by applicant]
US 9254352B2 · Kumar et al. · 2016 [cited by applicant]
US 9259237B2 · Quick et al. · 2016 [cited by applicant]
US 9265512B2 · Carrison et al. · 2016 [cited by applicant]
US 9283066B2 · Hopkins et al. · 2016 [cited by applicant]
US 9301769B2 · Brady et al. · 2016 [cited by applicant]
US 9351747B2 · Kugler et al. · 2016 [cited by applicant]
US 9402938B2 · Aklog et al. · 2016 [cited by applicant]
US 9439664B2 · Sos · 2016 [cited by applicant]
US 9439751B2 · White et al. · 2016 [cited by applicant]
US 9456834B2 · Folk · 2016 [cited by applicant]
US 9463035B1 · Greenhalgh et al. · 2016 [cited by applicant]
US 9463036B2 · Brady et al. · 2016 [cited by applicant]
US 9492635B2 · Beasley et al. · 2016 [cited by applicant]
US 9526864B2 · Quick · 2016 [cited by applicant]
US 9526865B2 · Quick · 2016 [cited by applicant]
US 9532792B2 · Galdonik et al. · 2017 [cited by applicant]
US 9545464B2 · Roche et al. · 2017 [cited by applicant]
US 9566073B2 · Kassab et al. · 2017 [cited by applicant]
US 9566179B2 · Andreas et al. · 2017 [cited by applicant]
US 9566424B2 · Pessin · 2017 [cited by applicant]
US 9579116B1 · Nguyen et al. · 2017 [cited by applicant]
US 9581942B1 · Shippert · 2017 [cited by applicant]
US 9616213B2 · Furnish et al. · 2017 [cited by applicant]
US 9636206B2 · Nguyen et al. · 2017 [cited by applicant]
US 9643035B2 · Mastenbroek · 2017 [cited by applicant]
US 9662129B2 · Galdonik et al. · 2017 [cited by applicant]
US 9700332B2 · Marchand et al. · 2017 [cited by applicant]
US 9717488B2 · Kassab et al. · 2017 [cited by applicant]
US 9717514B2 · Martin et al. · 2017 [cited by applicant]
Cited By (7)
US 12,310,608 US 12,364,496 US 12,465,382 US 12,558,112 US 12,558,486 US 12,685,549 US 12,702,538